Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer-Reference-Cited by-同舟云学术

Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer

Published:2017-03 Issue: Volume:605 Page:114-122
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

El Hadi Hicham,Abdellaoui-Maane Imane,Kottwitz Denise,El Amrani Manal,Bouchoutrouch Nadia,Qmichou Zineb,Karkouri Mehdi,ElAttar Hicham,Errihani Hassan,Fernandez Pedro L,Bakri Youssef,Sefrioui Hassan,Moumen Abdeladim

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference32 articles.

1. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets;Andersen;Cancer Res.,2004

2. Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories;Baehner;J. Clin. Oncol.,2010

3. Quantitative PCR and HER2 testing in breast cancer;Barberis;Am. J. Clin. Pathol.,2008

4. Future options with trastuzumab for primary systemic and adjuvant therapy;Baselga;Semin. Oncol.,2004

5. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology;Bast;J. Clin. Oncol.,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Inflammation and the NF-κB Signaling Pathway in Hirschsprung’s Disease;Biomolecules;2024-08-12

2. Think “HER2” different: integrative diagnostic approaches for HER2-low breast cancer;Pathologica;2023-12

3. HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?;International Journal of Molecular Sciences;2023-05-04

4. Functional and Bioinformatic Investigation of the Regulatory Region of HER2-Associated Enhancer GH17J039694, HER2-Enhancer1, in Breast Cancer (SKBR3 and MCF7) and non-Breast Cancer Cell Lines (HEK293) Using CRISPR/Cas9 Technology;Sarem Journal of Medical Research;2022-03-01

5. Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma;Annals of Translational Medicine;2022-01